Back

Prognosis of cardiac sarcoidosis in patients with implantable cardioverter defibrillator -primary versus secondary prevention-

18 June 2017 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster session 3 - Sudden cardiac death and implantable defibrillators Primary prevention (Sudden cardiac death and implantable defibrillators) EHRA Premium Access EHRA EUROPACE - CARDIOSTIM 2017

About the speaker

Photo
Doctor Miyo Nakano

Chiba University Graduate School of Medicine, Chiba (Japan)

16 More presentations in this session

Presentation thumbnail
Long-term effectiveness and complications of ICDs in patients with hypertrophic cardiomyopathy
Miss N. Calvo Galiano (Zaragoza, ES)
Abstract
Presentation thumbnail
Prophylactic cardioverter-defibrillator implantation in systolic heart failure: does the aetiology of cardiomyopathy matter?
Miss M. Braga (Porto, PT)
Abstract Slides
Presentation thumbnail
Performance of sudden cardiac death risk score at the time of device replacement for patients with hypertrophic cardiomyopathy
Doctor M. Biffi (Bologna, IT)
Abstract Slides
Presentation thumbnail
Predictors of future implantable cardioverter-defibrillators appropriate therapies in patients undergoing generator replacement: who still benefiting from implantable cardioverter-defibrillators?
Doctor M. Madeira (Coimbra, PT)
Abstract Slides
Presentation thumbnail
Influence of beta-blocker therapy on the incidence and on the timing of heart failure decompensation after an ICD shock.
Professor J. Jimenez-Candil (Salamanca, ES)
Abstract Slides

Access the full session

Session thumbnail
Poster session 3 - Sudden cardiac death and implantable defibrillators

The Event

Event poster

EHRA EUROPACE - CARDIOSTIM 2017

18 June - 21 June 2017

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources